Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 1, 2000, Pages 89-94

  Robnett, Theodore J ^a   Machtay, Mitchell ^a   Vines, Eugene F ^a   McKenna, Michael G ^a   Algazy, Kenneth M ^a   McKenna, W Gillies ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemoradiation; Lung cancer; Radiation pneumonitis

Indexed keywords

ANTITUSSIVE AGENT; NARCOTIC AGENT; PACLITAXEL; STEROID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COUGHING; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OXYGEN THERAPY; PRIORITY JOURNAL; RADIATION PNEUMONIA; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; SEX FACTORS;

EID: 0034255588     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00648-9     Document Type: Article

References (26)

1. Byhardt R.W. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 32:1995;1513-1525.
2. Komaki R., Cox J.D., Hartz A.J., et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol. 8:1985;362-370.
3. ASCO Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997;15:2996-3018.
4. AJCC American Joint Committee on Cancer (AJCC) cancer staging manual. Philadelphia: Lippincott-Raven; 1997.
5. Bonomi P., Siddiqui S., Lincoln S., et al. Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer. Semin Oncol. 6:(Suppl. 16):1996;102-107.
6. Furuse K., Nobuyuki N., Takada M., et al. Phase II study of 3-hour infusion paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer. Oncol. 54:1997;298-303.
7. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Belmont: Duxbury Press; 1988. p. 512-516.
8. Byhardt R.W., Martin L., Pajak T.F., Shin K.H., Emami B., Cox J.D. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) Analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys. 27:1993;537-544.
9. Gillam P.M.S., Heaf P.J.D., Hoffbrand B.I., et al. Chronic bronchitis and radiotherapy of the lung. Lancet. 1:1964;1245-1248.
10. Hellman S., Kligerman M.M., von Essen C.F., Scibetta M.P. Sequelae of radical radiotherapy of carcinoma of the lung. Radiology. 82:1964;1055-1061.
11. Perez C.A., Stanley K., Rubin P., et al. A prospective study of various radiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung Preliminary report by the Radiation Therapy Oncology Group. Cancer. 45:1980;2744-2753.
12. Sherman D.M., Carabell S.C., Belli J.A., et al. The effect of dose rate and Adriamycin on the tolerance of thoracic radiation in mice. Int J Radiat Oncol Biol Phys. 8:1982;45-51.
13. vonderMasse H, Overgaard J, Vaeth M. Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 1986;5:245-257.
14. Byhardt R.W., Scott C., Sause W.T., Emami B., Komaki R., Fisher B., Lee J.S., Lawton C. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 42:1998;469-478.
15. Jeremic B., Shibamoto Y., Acimovic L., Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small cell lung cancer A randomized study. J Clin Oncol. 14:1996;1065-1070.
16. Schaake-Konig C., Van dan Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med. 326:1992;524-530.
17. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III non-small cell lung cancer. N Engl J Med. 323:1990;940-945.
18. Roberts C.M., Foulcher E., Zaunders J.J., Bryant D.H., Freund J., Cairns D., Penny R., Morgan G.W., Breit S.N. Radiation pneumonitis A possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med. 118:1993;696-700.
19. Morgan G.W., Breit S.N. Radiation and the lung A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys. 31:1995;361-369.
20. Choi N.C., Kanarek D.J., Kazemi H. Physiologic changes in pulmonary function after thoracic radiotherapy for lung cancer and the role of regional pulmonary function studies in predicting post-radiotherapy pulmonary function. Cancer Treatment Symposia. 2:1985;119-130.
21. Roach M.R., Gandara D.R., Yuo H.S., Swift P.S., Kroll S., Shrieve D.C., Wara W.M., Margolis L., Phillips T.L. Radiation pneumonitis following combined modality therapy for lung cancer Analysis of prognostic factors. J Clin Oncol. 13:1995;2606-2612.
22. Armstrong J.G., Zelefsky M.J., Leibel S.A., Burman C., Han C., Harrison L.B., Kutcher G.J., Fuks Z.Y. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol. 6:1995;693-697.
23. Graham M.V., Purdy J.A., Emami B., et al. 3-D conformal radiotherapy for lung cancer The Washington University experience. Front Radiat Ther Oncol. 29:1996;188-198.
24. Kwa S.L., Lebesque J.V., Theuws J.C., Marks L.B., Munley M.T., Bentel G., Oetzel D., Spahn U., Graham M.V., Drzymala R.E., Purdy J.A., Lichter A.S., Martel M.K., TenHaken R.K. Radiation pneumonitis as a function of mean lung dose An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 42:1998;1-9.
25. Martel M.K., TenHaken R., Hazuka M.B., et al. DVH and 3-D treatment planning evaluation of patients with pneumonitits. Int J Radiat Oncol Biol Phys. 28:1994;575-581.
26. Robertson J.M., TenHaken R.K., Hazuka M.B., Turrisi A.T., Martel M.K., Pu A.T., Littles J.F., Martinez F.J., Francis I.R., Quint L.E., Lichter A.S. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1079-1085.